Test ID: MPLB
MPL Exon 10 Mutation Detection, Blood
Secondary ID
A test code used for billing and in test definitions created prior to November 2011
89776
NY State Approved
Indicates the status of NY State approval and if the test is orderable for NY State clients.
Yes
Useful For
Suggests clinical disorders or settings where the test may be helpful
Aiding in the distinction between a reactive cytosis and a myeloproliferative neoplasm
Testing Algorithm
Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.
See Myeloproliferative Neoplasm: A Diagnostic Approach to Peripheral Blood Evaluation in Special Instructions.
Special Instructions and Forms
Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test
Method Name
A short description of the method used to perform the test
Mutation Detection in DNA Using Sanger Sequencing
(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)
Reporting Name
A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
MPL Exon 10 Mutation Detection, B
Aliases
Lists additional common names for a test, as an aid in searching
MPL S505
MPL W515
myeloproliferative leukemia virus oncogene
MPL W515
myeloproliferative leukemia virus oncogene


